BRYJA, Vítězslav, Pavel KREJČÍ, Markéta KAUCKÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER, Alois KOZUBÍK, Jana KOTAŠKOVÁ and Karla PLEVOVÁ. Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method. 2015. |
Other formats:
BibTeX
LaTeX
RIS
@misc{1341556, author = {Bryja, Vítězslav and Krejčí, Pavel and Kaucká, Markéta and Pospíšilová, Šárka and Mayer, Jiří and Kozubík, Alois and Kotašková, Jana and Plevová, Karla}, keywords = {B Cell; Chronic Lymphotetic Leukemia; WNT/PCP Signaling Pathway}, language = {eng}, title = {Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method}, year = {2015} }
TY - PAT ID - 1341556 AU - Bryja, Vítězslav - Krejčí, Pavel - Kaucká, Markéta - Pospíšilová, Šárka - Mayer, Jiří - Kozubík, Alois - Kotašková, Jana - Plevová, Karla PY - 2015 TI - Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method KW - B Cell KW - Chronic Lymphotetic Leukemia KW - WNT/PCP Signaling Pathway N2 - The invention provides a method of determination of diagnosis and prognosis of B-cell chronic lymphocytic leukemia from a biological sample collected from the body of a patient, wherein the status of Wnt/PCP signaling pathway is determined. Within the framework of the present invention the relation of CLL and molecular signaling pathway Wnt/PCP the components of which are markedly up-regulated in B-lymphocytes of the patients suffering from CLL was identified. The status of the Wnt/PCP signaling pathway can be determined, e.g., by the determination of the expression of components of said signaling pathway or by the determination of migration of CLL cells in the gradient of a chemokine in the presence of the ligand of said signaling pathway. The invention also relates to suitable oligonucleotides for use in the method of determination of expression of the signaling pathway components. ER -
BRYJA, Vítězslav, Pavel KREJČÍ, Markéta KAUCKÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER, Alois KOZUBÍK, Jana KOTAŠKOVÁ and Karla PLEVOVÁ. \textit{Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method}. 2015.
|